Henlius Has First ‘China-Developed’ Biosimilar Accepted For EMA Review

 
• By Penelope MacRae
  
China_EU_Flags
Henlius is boasting the first China-developed biosimilar to be accepted for review by the EMA • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products